Table 2. HPV status of the samples.
ID |
Infant sex |
Delivery mode (VD vaginal delivery, CS caesarean section) |
Gestation weeks |
Infant oral (HPV type) |
Timepoint when infant oral samples were collected |
Mother’s milk (HPV type) |
Timepoint when breast milk samples were collected |
---|---|---|---|---|---|---|---|
1 | female | VD | 42.0 | (-) | at 2 months | at birth | |
2 | female | VD | 41.0 | 33,59 | at birth | at birth | |
3 | female | CS | 35.4 | (-) | at birth | at birth | |
4 | female | VD | 40.1 | at 2 months | at birth | ||
5 | male | VD | 37.6 | at 2 months | at 2 months | ||
6 | female | VD | 40.1 | at 2 months | at birth | ||
7 | male | VD | 42.0 | at 2 months | at birth | ||
8 | female | VD | 39.4 | at 2 months | at birth | ||
9 | female | VD | 38.3 | at 2 months | (-) | at birth | |
10* | male | VD | 38.0 | at 2 months | at birth | ||
11* | male | VD | 38.0 | 18 | at 2 months | at birth | |
12 | male | CS | 38.5 | at 2 months | at birth | ||
13 | male | CS | 42.2 | at 2 months | at birth | ||
14 | female | VD | 41.5 | 18 | at 2 months | at birth | |
15 | male | VD | 41.0 | at 2 months | at birth | ||
16 | male | VD | 39.0 | at birth | at birth | ||
17 | female | CS | 40.0 | 16 | at birth | at birth | |
18 | male | CS | 42.1 | at 2 months | at birth | ||
19 | female | CS | 42.4 | 6 | at 2 months | at birth | |
20 | female | CS | 41.1 | at 2 months | at birth | ||
21 | female | VD | 39.6 | at 2 months | at birth | ||
22 | male | CS | 38.4 | 66 | at birth | (-) | at birth |
23 | female | VD | 39.0 | 16,33(-) | at birth | at birth | |
24 | male | VD | 42.0 | at birth | 16 | at birth | |
25 | female | VD | 40.4 | 16 | at birth | at birth | |
26 | female | CS | 39.0 | at 2 months | at birth | ||
27 | male | VD | 40.4 | 16 | at birth | at birth | |
28 | female | VD | 41.0 | 70 | at 2 months | at birth | |
29 | female | CS | 39.1 | at 2 months | at birth | ||
30 | female | VD | 41.6 | 16 | at 2 months | at birth | |
31 | female | CS | 40.6 | at 2 months | at birth | ||
32 | male | VD | 38.3 | 66 | at birth | at 2 months | |
33 | female | VD | 40.6 | at 2 months | at 2 months | ||
34 | female | VD | 40.0 | 58 | at birth | 6 | at birth |
35 | female | CS | 39.0 | at birth | 6 | at birth | |
36 | female | CS | 41.4 | at birth | (-) | at birth | |
37 | male | VD | 39.6 | 6(-) | at birth | at birth | |
38 | male | CS | 35.3 | 16 | at birth | (-) | at birth |
39 | male | VD | 36.6 | 6(-) | at birth | at birth | |
40 | male | CS | 42.0 | 16 | at birth | at 2 months |
*twins
(-) samples not included in the analyses because of the poor DNA quality